Quantum Genomics SAS Pioneers New Cardiovascular Therapies with Innovative Research and Strategic Partnerships
Quantum Genomics SAS is a France-based biopharmaceutical company advancing cardiovascular therapies through innovative research and collaborations, aiming to address unmet medical needs in hypertension and heart failure.
2 minutes to read